FANCD2 Is a Potential Therapeutic Target and Biomarker in Alveolar Rhabdomyosarcoma Harboring the PAX3-FOXO1 Fusion Gene Article

Singh, Mamata, Leasure, Justin M, Chronowski, Christopher et al. (2014). FANCD2 Is a Potential Therapeutic Target and Biomarker in Alveolar Rhabdomyosarcoma Harboring the PAX3-FOXO1 Fusion Gene . CLINICAL CANCER RESEARCH, 20(14), 3884-3895. 10.1158/1078-0432.CCR-13-0556

Open Access

cited authors

  • Singh, Mamata; Leasure, Justin M; Chronowski, Christopher; Geier, Brian; Bondra, Kathryn; Duan, Wenrui; Hensley, Lauren A; Villalona-Calero, Miguel; Li, Ning; Vergis, Anthony M; Kurmasheva, Raushan T; Shen, Changxian; Woods, Gary; Sebastian, Nikhil; Fabian, Denise; Kaplon, Rita; Hammond, Sue; Palanichamy, Kamalakannan; Chakravarti, Arnab; Houghton, Peter J

sustainable development goals

authors

publication date

  • July 15, 2014

webpage

published in

keywords

  • ACTIVATION
  • CANCER
  • CHILDRENS ONCOLOGY GROUP
  • CROSS-LINK REPAIR
  • Life Sciences & Biomedicine
  • Oncology
  • PATHWAY
  • PROTEIN
  • SET ENRICHMENT ANALYSIS
  • STRATEGY
  • SURVIVAL
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • AMER ASSOC CANCER RESEARCH

start page

  • 3884

end page

  • 3895

volume

  • 20

issue

  • 14